Vlad Vitoc - 30 Dec 2022 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Vlad Vitoc
Issuer symbol
MAIA
Transactions as of
30 Dec 2022
Transactions value $
$9,894
Form type
4
Filing time
04 Jan 2023, 06:29:00 UTC
Previous filing
20 Sep 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $1,435 +410 +0.05% $3.50 789,531 30 Dec 2022 Direct F1
transaction MAIA Common Stock Purchase $8,459 +2,324 +0.29% $3.64 791,855 03 Jan 2023 Direct F1, F2
holding MAIA Common Stock 210,000 30 Dec 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.
F2 The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.51 to $3.70, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F3 These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.